Helicobacter Test Infai For Children Of The Age 3-11

Helicobacter Test Infai for Children aged 3‑11 is an in‑vitro diagnostic kit that utilizes the 13C‑Urea breath test principle. The kit contains the stable‑isotope 13C‑Urea as the active ingredient and is designed for oral administration to detect Helicobacter pylori infection in pediatric patients. It is marketed in the European Union and supplied as a ready‑to‑use kit. The test follows clinical protocols and offers a non‑invasive option for confirming infection.

Helicobacter Test Infai for Children is indicated for the detection of Helicobacter pylori infection in pediatric patients aged 3 to 11 years. The 13C‑Urea breath test kit is used as a diagnostic tool to support clinical decisions regarding eradication therapy.

- Assess presence of active H. pylori infection in children. - Aid in confirming successful eradication after treatment. - Provide a non‑invasive alternative to endoscopic biopsy for diagnosis. - Suitable for use in primary care, pediatric gastroenterology, and hospital settings. - Complement other diagnostic methods such as serology or stool antigen testing when needed.

The 13C‑Urea breath test is generally well tolerated, but some individuals may experience mild or, rarely, serious reactions.

Common: - A temporary metallic or sweet taste in the mouth lasting a few minutes after ingestion. - Mild abdominal discomfort, bloating, or gas that resolves without treatment. - Slight nausea or an upset stomach that does not require medication. - Brief headache that subsides within an hour.

Serious: - Allergic reaction such as skin rash, itching, hives, or facial swelling. - Severe respiratory difficulty, wheezing, or throat tightness indicating possible anaphylaxis. - Persistent vomiting or diarrhea lasting more than several hours. - Unexplained fainting, dizziness, or loss of consciousness requiring medical attention.

When using the Helicobacter Test Infai for Children, certain precautions should be observed to ensure accurate results and patient safety.

- Verify the child is within the approved age range (3‑11 years) before testing. - Ensure the child has fasted according to the test protocol, typically 2‑4 hours before administration. - Review any recent antibiotic, proton‑pump inhibitor, or bismuth use, as these may affect test accuracy. - Consider underlying medical conditions such as severe asthma or chronic lung disease that could influence breath sample collection. - Inform the caregiver about the need to avoid certain foods or drinks containing carbon‑13 labeled substances prior to the test. - Document any known allergies to urea or related compounds before administration.

Certain substances and medications can interfere with the 13C‑Urea breath test results or increase the risk of adverse reactions.

Avoid: - Recent use (within 2 weeks) of antibiotics targeting H. pylori, such as clarithromycin, amoxicillin, or metronidazole. - Proton‑pump inhibitors (e.g., omeprazole, lansoprazole) taken within 2 weeks prior to testing. - Bismuth‑containing compounds (e.g., bismuth subsalicylate) used within the preceding week. - Consumption of carbon‑13 enriched foods or supplements on the day of the test.

Use with caution: - Over‑the‑counter antacids taken within 24 hours before the test. - Herbal remedies that may affect gastric acidity, such as peppermint or ginger extracts. - Chronic respiratory conditions that could alter breath sample composition.